Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | (FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | (Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -45.51%153.69M | -18.61%233.37M | -16.39%254.07M | -9.70%270.98M | -9.70%270.98M | -12.33%282.07M | -18.18%286.75M | -19.85%303.86M | -17.52%300.07M | -17.52%300.07M |
-Cash and cash equivalents | 20.05%43.57M | -0.70%34.88M | 34.04%49.49M | 14.56%49.83M | 14.56%49.83M | -30.34%36.29M | -0.76%35.12M | -14.29%36.92M | -43.70%43.5M | -43.70%43.5M |
-Short-term investments | -55.19%110.12M | -21.11%198.5M | -23.36%204.58M | -13.81%221.15M | -13.81%221.15M | -8.85%245.78M | -20.14%251.62M | -20.56%266.94M | -10.46%256.58M | -10.46%256.58M |
Receivables | 187.80%236K | 30.50%415K | 247.43%1.22M | 4.08%1.66M | 4.08%1.66M | -71.82%82K | 38.86%318K | -23.75%350K | -90.44%1.6M | -90.44%1.6M |
-Accounts receivable | 187.80%236K | 30.50%415K | 247.43%1.22M | 483.33%350K | 483.33%350K | -71.82%82K | 38.86%318K | -23.75%350K | -99.61%60K | -99.61%60K |
-Accrued interest receivable | ---- | ---- | ---- | -14.29%1.08M | -14.29%1.08M | ---- | ---- | ---- | 24.75%1.26M | 24.75%1.26M |
-Taxes receivable | ---- | ---- | ---- | -16.36%230K | -16.36%230K | ---- | ---- | ---- | -32.93%275K | -32.93%275K |
Prepaid assets | -12.18%3.76M | -23.19%3.72M | -28.00%3.81M | 33.04%2.4M | 33.04%2.4M | -14.02%4.29M | 8.27%4.84M | 36.73%5.29M | 11.08%1.8M | 11.08%1.8M |
Restricted cash | --152K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other current assets | ---- | ---- | ---- | -26.24%343K | -26.24%343K | ---- | ---- | ---- | 11.78%465K | 11.78%465K |
Total current assets | -44.89%157.84M | -18.64%237.51M | -16.29%259.09M | -9.40%275.38M | -9.40%275.38M | -12.41%286.43M | -17.81%291.91M | -19.28%309.5M | -20.55%303.94M | -20.55%303.94M |
Non current assets | ||||||||||
Net PPE | 33.92%3.21M | 6.49%2.78M | 24.99%3.42M | -24.11%2.14M | -24.11%2.14M | -20.35%2.4M | -16.87%2.61M | -16.58%2.74M | -19.06%2.82M | -19.06%2.82M |
-Gross PPE | --3.21M | --2.78M | --3.42M | 3.69%11.28M | 3.69%11.28M | ---- | ---- | ---- | 2.49%10.88M | 2.49%10.88M |
-Accumulated depreciation | ---- | ---- | ---- | -13.40%-9.14M | -13.40%-9.14M | ---- | ---- | ---- | -13.00%-8.06M | -13.00%-8.06M |
Investments and advances | --75.27M | 0.04%7.93M | ---- | --0 | --0 | --0 | -56.60%7.93M | -52.35%2.99M | 10.32%30.51M | 10.32%30.51M |
Other non current assets | -95.92%14K | -54.00%161K | -51.18%166K | -2.01%341K | -2.01%341K | -4.19%343K | -2.78%350K | -8.85%340K | 70.59%348K | 70.59%348K |
Total non current assets | 2,761.90%78.5M | -0.16%10.87M | -40.87%3.59M | -92.64%2.48M | -92.64%2.48M | -91.80%2.74M | -49.99%10.88M | -38.89%6.07M | 7.45%33.68M | 7.45%33.68M |
Total assets | -18.27%236.34M | -17.97%248.38M | -16.76%262.68M | -17.70%277.86M | -17.70%277.86M | -19.77%289.18M | -19.67%302.79M | -19.78%315.57M | -18.43%337.61M | -18.43%337.61M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 96.87%3.14M | 230.22%4.59M | -17.59%2.02M | -55.55%2.34M | -55.55%2.34M | -80.36%1.6M | -52.98%1.39M | -40.77%2.45M | -24.98%5.25M | -24.98%5.25M |
-accounts payable | 96.87%3.14M | 230.22%4.59M | -17.59%2.02M | -55.55%2.34M | -55.55%2.34M | -80.36%1.6M | -52.98%1.39M | -40.77%2.45M | -24.98%5.25M | -24.98%5.25M |
Current accrued expenses | 177.84%10.02M | 236.17%10.77M | 102.93%7.61M | 41.16%4.98M | 41.16%4.98M | 13.47%3.61M | -59.71%3.2M | -16.31%3.75M | 19.38%3.53M | 19.38%3.53M |
Current debt and capital lease obligation | 383.33%754K | 462.75%861K | 610.60%1.07M | -22.94%131K | -22.94%131K | -22.39%156K | -40.93%153K | -52.22%151K | -51.57%170K | -51.57%170K |
-Current debt | ---- | ---- | ---- | -22.94%131K | -22.94%131K | -22.39%156K | -40.93%153K | -52.22%151K | -51.57%170K | -51.57%170K |
-Current capital lease obligation | --754K | --861K | --1.07M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other current liabilities | ---- | ---- | ---- | 79.52%-17K | 79.52%-17K | 66.00%-34K | 56.90%-50K | 50.38%-66K | 44.30%-83K | 44.30%-83K |
Current liabilities | 104.17%17.61M | 99.61%16.22M | 61.94%13.18M | -8.19%11.83M | -8.19%11.83M | -40.26%8.62M | -42.03%8.13M | -23.45%8.14M | -7.78%12.88M | -7.78%12.88M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 11,576.92%1.52M | 862.26%510K | 507.61%559K | ---- | ---- | -92.31%13K | -74.40%53K | -62.14%92K | -56.48%131K | -56.48%131K |
-Long term debt | ---- | ---- | ---- | ---- | ---- | -92.31%13K | -74.40%53K | -62.14%92K | -56.48%131K | -56.48%131K |
-Long term capital lease obligation | --1.52M | --510K | --559K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current liabilities | ---- | ---- | ---- | -79.52%17K | -79.52%17K | -66.00%34K | -56.90%50K | -50.38%66K | -44.30%83K | -44.30%83K |
Total non current liabilities | 3,129.79%1.52M | 395.15%510K | 253.80%559K | -92.06%17K | -92.06%17K | -82.53%47K | -68.11%103K | -57.98%158K | -52.44%214K | -52.44%214K |
Total liabilities | 120.57%19.13M | 103.30%16.73M | 65.60%13.74M | -9.56%11.85M | -9.56%11.85M | -41.03%8.67M | -42.62%8.23M | -24.63%8.3M | -9.17%13.1M | -9.17%13.1M |
Shareholders'equity | ||||||||||
Share capital | 0.72%140K | 0.00%139K | 0.72%139K | 0.72%139K | 0.72%139K | 0.72%139K | 1.46%139K | 0.73%138K | 0.73%138K | 0.73%138K |
-common stock | 0.72%140K | 0.00%139K | 0.72%139K | 0.72%139K | 0.72%139K | 0.72%139K | 1.46%139K | 0.73%138K | 0.73%138K | 0.73%138K |
Retained earnings | -11.36%-730.89M | -11.07%-711.31M | -11.01%-691.89M | -11.66%-672.93M | -11.66%-672.93M | -13.27%-656.33M | -14.34%-640.44M | -15.94%-623.24M | -16.47%-602.65M | -16.47%-602.65M |
Paid-in capital | 1.16%947.75M | 0.77%942.52M | 1.02%940.56M | 1.25%939M | 1.25%939M | 1.27%936.9M | 1.37%935.28M | 1.23%931.06M | 1.18%927.42M | 1.18%927.42M |
Gains losses not affecting retained earnings | 207.21%223K | 169.93%293K | 117.66%121K | 48.84%-199K | 48.84%-199K | -230.16%-208K | -249.17%-419K | -4,129.41%-685K | -357.62%-389K | -357.62%-389K |
Total stockholders'equity | -22.56%217.22M | -21.36%231.64M | -18.98%248.94M | -18.03%266.01M | -18.03%266.01M | -18.87%280.51M | -18.76%294.56M | -19.64%307.27M | -18.76%324.52M | -18.76%324.52M |
Total equity | -22.56%217.22M | -21.36%231.64M | -18.98%248.94M | -18.03%266.01M | -18.03%266.01M | -18.87%280.51M | -18.76%294.56M | -19.64%307.27M | -18.76%324.52M | -18.76%324.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |